Meticillin-resistant Staphylococcus aureus

John M. Boyce; Barry Cookson; Keryn Christiansen; Satoshi Hori; Jaana Vuopio-Varkila; Sesin Kocagöz; A. Yasemin Öztop; Christina M.J.E. Vandenbroucke-Grauls; Stephan Harbarth; Didier Pittet

doi:10.1016/S1473-3099(05)70243-7

Meticillin-resistant Staphylococcus aureus

John M. Boyce^*
, Barry Cookson
, Keryn Christiansen
, Satoshi Hori
, Jaana Vuopio-Varkila
, Sesin Kocagöz
, A. Yasemin Öztop
, Christina M.J.E. Vandenbroucke-Grauls
, Stephan Harbarth
, Didier Pittet

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

162 Citations (Scopus)

Abstract

Meticillin was introduced in 1959 to treat infections caused by penicillin-resistant Staphylococcus aureus. In 1961 there were reports from the UK of S aureus isolates that had acquired resistance to meticillin (meticillin-resistant S aureus, MRSA). Similar MRSA isolates were soon found in other European countries, and later from Japan, Australia, and the USA. Today MRSA is a major cause of hospital-acquired infections, and a serious public-health concern. In this forum, we present different perspectives from across the globe to better understand the complexity of the problem, and examine the challenges that individual countries face in trying to control the spread of MRSA.

Original language	English
Pages (from-to)	653-663
Number of pages	11
Journal	Lancet Infectious Diseases
Volume	5
Issue number	10
DOIs	https://doi.org/10.1016/S1473-3099(05)70243-7
Publication status	Published - Oct 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1473-3099(05)70243-7

Cite this

@article{eb2c1ef8fb594cf980e2e2f83f86bfb8,

title = "Meticillin-resistant Staphylococcus aureus",

abstract = "Meticillin was introduced in 1959 to treat infections caused by penicillin-resistant Staphylococcus aureus. In 1961 there were reports from the UK of S aureus isolates that had acquired resistance to meticillin (meticillin-resistant S aureus, MRSA). Similar MRSA isolates were soon found in other European countries, and later from Japan, Australia, and the USA. Today MRSA is a major cause of hospital-acquired infections, and a serious public-health concern. In this forum, we present different perspectives from across the globe to better understand the complexity of the problem, and examine the challenges that individual countries face in trying to control the spread of MRSA.",

author = "Boyce, \{John M.\} and Barry Cookson and Keryn Christiansen and Satoshi Hori and Jaana Vuopio-Varkila and Sesin Kocag{\"o}z and {\"O}ztop, \{A. Yasemin\} and Vandenbroucke-Grauls, \{Christina M.J.E.\} and Stephan Harbarth and Didier Pittet",

year = "2005",

month = oct,

doi = "10.1016/S1473-3099(05)70243-7",

language = "English",

volume = "5",

pages = "653--663",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "10",

}

TY - JOUR

T1 - Meticillin-resistant Staphylococcus aureus

AU - Boyce, John M.

AU - Cookson, Barry

AU - Christiansen, Keryn

AU - Hori, Satoshi

AU - Vuopio-Varkila, Jaana

AU - Kocagöz, Sesin

AU - Öztop, A. Yasemin

AU - Vandenbroucke-Grauls, Christina M.J.E.

AU - Harbarth, Stephan

AU - Pittet, Didier

PY - 2005/10

Y1 - 2005/10

N2 - Meticillin was introduced in 1959 to treat infections caused by penicillin-resistant Staphylococcus aureus. In 1961 there were reports from the UK of S aureus isolates that had acquired resistance to meticillin (meticillin-resistant S aureus, MRSA). Similar MRSA isolates were soon found in other European countries, and later from Japan, Australia, and the USA. Today MRSA is a major cause of hospital-acquired infections, and a serious public-health concern. In this forum, we present different perspectives from across the globe to better understand the complexity of the problem, and examine the challenges that individual countries face in trying to control the spread of MRSA.

AB - Meticillin was introduced in 1959 to treat infections caused by penicillin-resistant Staphylococcus aureus. In 1961 there were reports from the UK of S aureus isolates that had acquired resistance to meticillin (meticillin-resistant S aureus, MRSA). Similar MRSA isolates were soon found in other European countries, and later from Japan, Australia, and the USA. Today MRSA is a major cause of hospital-acquired infections, and a serious public-health concern. In this forum, we present different perspectives from across the globe to better understand the complexity of the problem, and examine the challenges that individual countries face in trying to control the spread of MRSA.

UR - https://www.scopus.com/pages/publications/25644461238

U2 - 10.1016/S1473-3099(05)70243-7

DO - 10.1016/S1473-3099(05)70243-7

M3 - Comment/debate

C2 - 16183520

AN - SCOPUS:25644461238

SN - 1473-3099

VL - 5

SP - 653

EP - 663

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 10

ER -

Meticillin-resistant Staphylococcus aureus

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this